Form S-4/A AIR INDUSTRIES GROUP
http://archive.fast-edgar.com/20261022/AE22C22DLC22QTB2222R2ZY2PTGQ2222E282
Filed on: October 22, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Xencor Presents Phase 1 Dose Selection Data for XmAb819, a Potential First-in-Class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Patients With Advanced Clear Cell Renal Cell Carcinoma and
- XRP Price Prediction: Patient Holders Wait on $1.49 as Pepeto Buyers Chase Returns Before Listing
- Johnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTACâ„¢ molecule
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share